TickerFactsScreenerDevelopers

Inmune Bio, Inc. (INMB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $141.7K2017: $1.37M2018: $186.2K2019: $7.00M2020: $21.97M2021: $74.81M2022: $52.15M2023: $35.85M2024: $20.92M2025: $24.75M$24.75M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$24.75M+18.3%
2024$20.92M-41.6%
2023$35.85M-31.3%
2022$52.15M-30.3%
2021$74.81M+240.6%
2020$21.97M+214.0%
2019$7.00M+3657.2%
2018$186.2K-86.4%
2017$1.37M+867.6%
2016$141.7K—